Medical foods market seen reaching $39.1B by 2033

Persistence Market Research says the global medical foods market will rise from $26.9 billion in 2026 to $39.1 billion by 2033, driven by chronic disease management, aging populations and broader use of clinical nutrition. North America leads now, while Asia Pacific is emerging as a high-growth region.

Why it matters: - Medical foods are becoming a bigger part of disease management as providers look for nutritional tools that support treatment plans. - Growth in chronic disease, metabolic disorders and aging populations is expanding demand for products used under medical supervision. - The shift matters for hospitals, specialty clinics and homecare providers that are integrating clinical nutrition into care.

What happened: - Persistence Market Research قيمed the global medical foods market at US$ 26.9 billion in 2026. - The firm projects the market will reach US$ 39.1 billion by 2033. - The forecast implies a compound annual growth rate of 5.5% from 2026 to 2033. - The report was published June 29, 2026. - The company offers a free sample report, report customization and full report access.

The details: - Medical foods are specially formulated nutritional products for the dietary management of specific diseases or health conditions under medical supervision. - The market serves patients with chronic illnesses, metabolic disorders, neurological conditions, gastrointestinal diseases and other health complications. - Rising awareness of clinical nutrition, higher healthcare spending and a growing burden of chronic disease are pushing adoption. - Physician recommendations, patient awareness and demand for disease-specific nutrition are supporting sales. - The report highlights personalized nutrition as a growing trend across disease-specific therapeutic uses. - Powder and ready-to-consume products are gaining popularity because they are convenient and support patient compliance. - Hospitals remain a major end user because of physician-supervised nutritional therapy and higher patient admissions. - Specialty clinics and long-term care facilities are also important buyers. - Home healthcare is emerging as a stronger channel as patients seek nutrition support outside hospitals.

Between the lines: - The forecast suggests medical foods are moving from a niche clinical product category toward broader use in mainstream care. - Product makers are likely focusing on formulations that address specific diseases while fitting into more personalized treatment plans. - North America’s lead points to the advantage of strong healthcare infrastructure, spending and awareness. - Asia Pacific’s faster growth signals an opening for manufacturers as healthcare access and clinical nutrition awareness improve.

What's next: - Product innovation in medical nutrition is expected to continue as companies target more disease-specific applications. - Demand is likely to rise as aging populations and lifestyle-related disorders increase the need for specialized nutritional support. - Market growth should remain strongest in regions where healthcare systems can support physician-guided nutrition therapy.

The bottom line: - Medical foods are on track for steady growth as clinical nutrition becomes a more accepted part of patient care.